Gamida Cell Analyst Ratings
Gamida Cell Analyst Ratings
While ratings are subjective and will change, the latest Gamida Cell (GMDA) rating was a reiterated with a price target of $0.00 to $11.00. The current price Gamida Cell (GMDA) is trading at is $1.25, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/16/2023 | 780% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 08/15/2023 | 380% | Needham | → $6 | Reiterates | Buy → Buy |
| 06/30/2023 | 380% | Needham | → $6 | Reiterates | Buy → Buy |
| 05/22/2023 | 780% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 05/19/2023 | 380% | JMP Securities | $8 → $6 | Maintains | Market Outperform |
| 05/16/2023 | 380% | Oppenheimer | $8 → $6 | Maintains | Outperform |
| 05/16/2023 | 380% | Needham | → $6 | Reiterates | Buy → Buy |
| 04/20/2023 | 380% | Needham | $8 → $6 | Maintains | Buy |
| 04/19/2023 | 780% | HC Wainwright & Co. | $5 → $11 | Maintains | Buy |
| 04/18/2023 | 300% | HC Wainwright & Co. | → $5 | Reiterates | → Buy |
| 04/17/2023 | 540% | JMP Securities | → $8 | Maintains | Market Perform |
| 03/28/2023 | 380% | JMP Securities | → $6 | Maintains | Market Outperform |
| 03/28/2023 | 300% | HC Wainwright & Co. | $22 → $5 | Maintains | Buy |
| 03/28/2023 | 540% | Oppenheimer | $10 → $8 | Maintains | Outperform |
| 11/22/2022 | 1100% | JMP Securities | → $15 | Maintains | Market Outperform |
| 11/22/2022 | 540% | Needham | $9 → $8 | Maintains | Buy |
| 11/15/2022 | 700% | Oppenheimer | $15 → $10 | Maintains | Outperform |
| 11/04/2022 | 1100% | JMP Securities | → $15 | Maintains | Market Outperform |
| 09/29/2022 | 620% | Needham | $12 → $9 | Maintains | Buy |
| 09/19/2022 | 1260% | JMP Securities | → $17 | Maintains | Market Outperform |
| 08/15/2022 | 1260% | JMP Securities | → $17 | Maintains | Market Outperform |
| 08/01/2022 | 1260% | JMP Securities | → $17 | Maintains | Market Outperform |
| 06/01/2022 | 1260% | JMP Securities | → $17 | Maintains | Market Outperform |
| 11/16/2021 | 860% | Needham | $14 → $12 | Maintains | Buy |
| 11/16/2021 | 1100% | Oppenheimer | $17 → $15 | Maintains | Outperform |
| 03/09/2021 | 1020% | Needham | $17 → $14 | Maintains | Buy |
| 07/01/2020 | — | Evercore ISI Group | Initiates Coverage On | → Outperform | |
| 05/26/2020 | 940% | Piper Sandler | → $13 | Initiates Coverage On | → Overweight |
| 05/21/2020 | 1260% | Needham | $19 → $17 | Maintains | Buy |
| 04/27/2020 | 1100% | HC Wainwright & Co. | → $15 | Initiates Coverage On | → Buy |
| 02/26/2020 | 1260% | BMO Capital | $19 → $17 | Maintains | Outperform |
| 09/20/2019 | 1180% | JMP Securities | → $16 | Initiates Coverage On | → Market Outperform |
| 11/20/2018 | 1500% | RBC Capital | → $20 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 08/16/2023 | 780% | HC Wainwright公司 | →$11 | 重申 | 購買→購買 |
| 2023年08月15日 | 380% | 李約瑟 | →$6 | 重申 | 購買→購買 |
| 2023/06/30 | 380% | 李約瑟 | →$6 | 重申 | 購買→購買 |
| 2023年05月22日 | 780% | HC Wainwright公司 | →$11 | 重申 | 購買→購買 |
| 2023年05月19日 | 380% | JMP證券 | $8→$6 | 維護 | 市場表現強於大盤 |
| 2023年05月16日 | 380% | 奧本海默 | $8→$6 | 維護 | 跑贏大盤 |
| 2023年05月16日 | 380% | 李約瑟 | →$6 | 重申 | 購買→購買 |
| 04/20/2023 | 380% | 李約瑟 | $8→$6 | 維護 | 買 |
| 04/19/2023 | 780% | HC Wainwright公司 | $5→$11 | 維護 | 買 |
| 04/18/2023 | 百分之三百 | HC Wainwright公司 | →$5 | 重申 | →購買 |
| 04/17/2023 | 540% | JMP證券 | →$8 | 維護 | 市場表現 |
| 03/28/2023 | 380% | JMP證券 | →$6 | 維護 | 市場表現強於大盤 |
| 03/28/2023 | 百分之三百 | HC Wainwright公司 | $22→$5 | 維護 | 買 |
| 03/28/2023 | 540% | 奧本海默 | $10→$8 | 維護 | 跑贏大盤 |
| 2022年11月22日 | 1100% | JMP證券 | →$15 | 維護 | 市場表現強於大盤 |
| 2022年11月22日 | 540% | 李約瑟 | $9→$8 | 維護 | 買 |
| 2022年11月15日 | 700% | 奧本海默 | $15→$10 | 維護 | 跑贏大盤 |
| 11/04/2022 | 1100% | JMP證券 | →$15 | 維護 | 市場表現強於大盤 |
| 09/29/2022 | 620% | 李約瑟 | $12→$9 | 維護 | 買 |
| 2022/09/19 | 1260% | JMP證券 | →$17 | 維護 | 市場表現強於大盤 |
| 2022年08月15日 | 1260% | JMP證券 | →$17 | 維護 | 市場表現強於大盤 |
| 08/01/2022 | 1260% | JMP證券 | →$17 | 維護 | 市場表現強於大盤 |
| 06/01/2022 | 1260% | JMP證券 | →$17 | 維護 | 市場表現強於大盤 |
| 2021年11月16日 | 860% | 李約瑟 | $14→$12 | 維護 | 買 |
| 2021年11月16日 | 1100% | 奧本海默 | $17→$15 | 維護 | 跑贏大盤 |
| 03/09/2021 | 1020% | 李約瑟 | $17→$14 | 維護 | 買 |
| 07/01/2020 | - | Evercore ISI集團 | 開始承保 | →跑贏大盤 | |
| 05/26/2020 | 940% | 派珀·桑德勒 | →$13 | 開始承保 | →超重 |
| 2020/05/21 | 1260% | 李約瑟 | $19→$17 | 維護 | 買 |
| 04/27/2020 | 1100% | HC Wainwright公司 | →$15 | 開始承保 | →購買 |
| 02/26/2020 | 1260% | 蒙特利爾銀行資本 | $19→$17 | 維護 | 跑贏大盤 |
| 2019年09月20日 | 1180% | JMP證券 | →$16 | 開始承保 | →市場跑贏大盤 |
| 2018年11月20日 | 1500% | 加拿大皇家銀行資本 | →$20 | 開始承保 | →跑贏大盤 |
What is the target price for Gamida Cell (GMDA)?
Gamida Cell(GMDA)的目標價是多少？
The latest price target for Gamida Cell (NASDAQ: GMDA) was reported by HC Wainwright & Co. on August 16, 2023. The analyst firm set a price target for $11.00 expecting GMDA to rise to within 12 months (a possible 780.00% upside). 20 analyst firms have reported ratings in the last year.
HC Wainwright&Co.於2023年8月16日報道了伽米達細胞(納斯達克代碼：GMDA)的最新目標價。這家分析公司將目標價定為11美元，預計GMDA值將在12個月內升至(可能上漲780.00%)。去年，已有20家分析公司公佈了評級。
What is the most recent analyst rating for Gamida Cell (GMDA)?
分析師對Gamida Cell(GMDA)的最新評級是什麼？
The latest analyst rating for Gamida Cell (NASDAQ: GMDA) was provided by HC Wainwright & Co., and Gamida Cell reiterated their buy rating.
分析師對伽米達細胞(納斯達克代碼：GMDA)的最新評級由HC Wainwright&Co.提供，伽米達細胞重申其買入評級。
When is the next analyst rating going to be posted or updated for Gamida Cell (GMDA)?
Gamida Cell(GMDA)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Gamida Cell, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Gamida Cell was filed on August 16, 2023 so you should expect the next rating to be made available sometime around August 16, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Gamida Cell的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Gamida Cell的最後一次評級是在2023年8月16日提交的，所以你應該預計下一次評級將在2024年8月16日左右提供。
Is the Analyst Rating Gamida Cell (GMDA) correct?
分析師對Gamida Cell(GMDA)的評級正確嗎？
While ratings are subjective and will change, the latest Gamida Cell (GMDA) rating was a reiterated with a price target of $0.00 to $11.00. The current price Gamida Cell (GMDA) is trading at is $1.25, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Gamida Cell(GMDA)評級被重申，目標價在0.00美元至11.00美元之間。目前Gamida Cell(GMDA)的交易價格為1.25美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。
